• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transpl Infect Dis Failed Antibody Response in a Renal Transplant Recipient With SARS-CoV-2 Infected

tetano

Editor, Senior Moderator
Transpl Infect Dis


. 2020 Jun 5;e13349.
doi: 10.1111/tid.13349. Online ahead of print.
Failed Antibody Response in a Renal Transplant Recipient With SARS-CoV-2 Infected


Zhiping Xia[SUP] 1 [/SUP], Xiaojun Liu[SUP] 2 [/SUP], Xiaoyan Hu[SUP] 1 [/SUP], Zibiao Zhong[SUP] 1 [/SUP], Yanfeng Wang[SUP] 1 [/SUP], Guizhu Peng[SUP] 1 [/SUP], Qifa Ye[SUP] 1 [/SUP]



Affiliations

Abstract

In late December 2019, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has been identified as a novel pathogen causing Coronavirus Disease 2019 (COVID-19) in Wuhan, China, subsequently spread to the rest of China and has been demonstrating a rapid global spread. Nucleic acid testing (NAT, tested by real-time polymerase chain reaction) of SARS-CoV-2 virus in oropharyngeal/nasal swab samples has been described to be extremely sensitive for the diagnose of SARS-CoV-2 infection, but false-negative results have been reported. Recent months, researches demonstrated the importance of IgM/IgG antibody detecting due to the unsatisfied positive rate of NAT, and the increasement IgM/IgG antibody was considered as a confirmed criteria of diagnosis in the official guides of the diagnosis and treatment of COVID-19 in China (7[SUP]th[/SUP] Edition) .




This article is protected by copyright. All rights reserved.
 
Back
Top